2020
DOI: 10.3390/biom10040534
|View full text |Cite
|
Sign up to set email alerts
|

Oxidized LDL Modify the Human Adipocyte Phenotype to an Insulin Resistant, Proinflamatory and Proapoptotic Profile

Abstract: Little information exists in humans on the regulation that oxidized low-density lipoprotein (oxLDL) exerts on adipocyte metabolism, which is associated with obesity and type 2 diabetes. The aim was to analyze the oxLDL effects on adipocytokine secretion and scavenger receptors (SRs) and cell death markers in human visceral adipocytes. Human differentiated adipocytes from visceral adipose tissue from non-obese and morbidly obese subjects were incubated with increasing oxLDL concentrations. mRNA expression of SR… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
13
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 71 publications
1
13
0
Order By: Relevance
“…In a recent study, Ampuero's team found that the levels of oxidized LDL cholesterol antibodies/HDL cholesterol were significantly higher in lean NAFLD patients [38]. When the body has elevated levels of oxidized LDL cholesterol antibodies, oxidized LDL cholesterol reduces insulin sensitivity by inhibiting signaling kinase and/or activating the nuclear factor-κB subunit 1 complex responsible for the cellular response to insulin, resulting in IR [39,40]. High oxidized LDL cholesterol levels will also increase the secretion of the proinflammatory adipocytokines TNF-α and IL6 [40], and the inflammatory response will further lead to IR, which will lead to lipid accumulation and form a vicious cycle [41].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In a recent study, Ampuero's team found that the levels of oxidized LDL cholesterol antibodies/HDL cholesterol were significantly higher in lean NAFLD patients [38]. When the body has elevated levels of oxidized LDL cholesterol antibodies, oxidized LDL cholesterol reduces insulin sensitivity by inhibiting signaling kinase and/or activating the nuclear factor-κB subunit 1 complex responsible for the cellular response to insulin, resulting in IR [39,40]. High oxidized LDL cholesterol levels will also increase the secretion of the proinflammatory adipocytokines TNF-α and IL6 [40], and the inflammatory response will further lead to IR, which will lead to lipid accumulation and form a vicious cycle [41].…”
Section: Discussionmentioning
confidence: 99%
“…When the body has elevated levels of oxidized LDL cholesterol antibodies, oxidized LDL cholesterol reduces insulin sensitivity by inhibiting signaling kinase and/or activating the nuclear factor-κB subunit 1 complex responsible for the cellular response to insulin, resulting in IR [39,40]. High oxidized LDL cholesterol levels will also increase the secretion of the proinflammatory adipocytokines TNF-α and IL6 [40], and the inflammatory response will further lead to IR, which will lead to lipid accumulation and form a vicious cycle [41]. In addition, previous studies have shown that in hepatic steatosis, an alteration in the activity of the transcription factors SREBP-1c and PPAR-alpha is observed.…”
Section: Discussionmentioning
confidence: 99%
“…In cultured murine adipocytes, oxLDLs inhibited the expression of leptin, an effect that was prevented by anti-CD36 antibodies and the ROS inhibitor N-acetylcysteine [ 160 ]; moreover, exposure to oxLDLs reduced the recruitment of glucose transporter 4 (GLUT4) to the plasma membrane, resulting in impaired insulin signaling [ 161 ]. Data obtained with human visceral fat from nonobese subjects strengthened this evidence, indicating that adipocytes exposed to oxLDLs assume an inflammatory phenotype with decreased leptin secretion, low insulin-induced glucose uptake, and altered expression of genes involved in apoptosis, autophagy, necrosis, and mitophagy [ 162 ].…”
Section: The Oxldl Signalingmentioning
confidence: 99%
“…It is known that ox-LDL is uptaken by visceral in vitro-differentiated adipocytes, and its increase stimulates the proinflammatory profile of these visceral adipocytes [ 18 ]. These effects are mediated by the binding of ox-LDL to its receptors, the SRs.…”
Section: Introductionmentioning
confidence: 99%
“…The aims of this study were to analyze in human visceral adipocytes (a) whether morbid obesity modified SRs expression, (b) whether hypoxia could produce an increase of SRs expression, as we had previously demonstrated for ox-LDL [ 18 ], (c) the effect of hypoxia on inflammation markers and (d) whether ox-LDL could increase the inflammatory response produced by hypoxia.…”
Section: Introductionmentioning
confidence: 99%